Vitamin Blue, Inc.
VTMB · OTC
12/31/2017 | 12/31/2016 | 12/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.63 | 0.00 | 11.62 | -7.01 |
| FCF Yield | 0.06% | -0.01% | -0.11% | -0.14% |
| EV / EBITDA | -520.80 | -24.73 | -6,054.35 | -389.73 |
| Quality | ||||
| ROIC | 8.05% | 7.55% | 50.95% | 44.91% |
| Gross Margin | 38.60% | 40.16% | 42.81% | 30.19% |
| Cash Conversion Ratio | -0.36 | -0.01 | 0.61 | 0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 24.47% | 27.42% | 4.71% | -7.30% |
| Free Cash Flow Growth | 563.45% | 0.00% | 9.58% | -63.66% |
| Safety | ||||
| Net Debt / EBITDA | -114.99 | -6.08 | -24.38 | -1.62 |
| Interest Coverage | -2.05 | -1.00 | -1.25 | -1.44 |
| Efficiency | ||||
| Inventory Turnover | 16.23 | 13.00 | 7.04 | 5.62 |
| Cash Conversion Cycle | -242.61 | -235.88 | -449.77 | -337.44 |